These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15735314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
    Offergeld R, Faensen D, Ritter S, Hamouda O.
    Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310
    [Abstract] [Full Text] [Related]

  • 3. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.
    Alvarez do Barrio M, González Díez R, Hernández Sánchez JM, Oyonarte Gómez S.
    Euro Surveill; 2005 Feb; 10(2):20-2. PubMed ID: 15735311
    [Abstract] [Full Text] [Related]

  • 4. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.
    CMAJ; 2003 Oct 14; 169(8):767-73. PubMed ID: 14557314
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003.
    Soldan K, Davison K, Dow B.
    Euro Surveill; 2005 Feb 14; 10(2):17-9. PubMed ID: 15735312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).
    Pillonel J, Laperche S, Etablissement Français du sang.
    Euro Surveill; 2005 Feb 14; 10(2):5-8. PubMed ID: 15735313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L, AbdulRahman M, John TJ, AlHashimi A.
    Transfusion; 2012 Nov 14; 52(11):2300-9. PubMed ID: 22691239
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ.
    Transfusion; 2005 Oct 14; 45(10):1670-5. PubMed ID: 16181219
    [Abstract] [Full Text] [Related]

  • 14. [Epidemiological data on infections among blood donors in Germany 2007].
    Offergeld R, Ritter S, Quabeck L, Hamouda O.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Nov 14; 53(11):1188-96. PubMed ID: 20976426
    [Abstract] [Full Text] [Related]

  • 15. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR, Kiely P, Keller AJ.
    Intern Med J; 2005 Oct 14; 35(10):592-8. PubMed ID: 16207258
    [Abstract] [Full Text] [Related]

  • 16. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ.
    N Engl J Med; 1996 Jun 27; 334(26):1685-90. PubMed ID: 8637512
    [Abstract] [Full Text] [Related]

  • 17. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.
    Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin CK, Tsoi WC, O'Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Lętowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S, Reesink HW.
    Vox Sang; 2012 Jan 27; 102(1):82-90. PubMed ID: 21933190
    [No Abstract] [Full Text] [Related]

  • 18. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA, Kotila TR, Akinyemi JO.
    Intervirology; 2008 Jan 27; 51(6):427-31. PubMed ID: 19321928
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C, Araújo F.
    Acta Med Port; 2013 Jan 27; 26(4):371-6. PubMed ID: 24016646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.